Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Pharmaceutical statistics

Showing results (41-50 of 1,234) with videos related to

Pageof 124
Sort By:
Pharmaceutical Statistics|April 3, 2008
Exploring changes in treatment effects across design stages in adaptive trialsTim Friede, Robin Henderson
Pharmaceutical Statistics|April 3, 2008
Statisticians and evidence--mote and beamStephen Senn
Pharmaceutical Statistics|May 16, 2008
Pharmacokinetic parameters estimation using adaptive Bayesian P-splines modelsAstrid Jullion, Philippe Lambert, Benoit Beck, et al.
Pharmaceutical Statistics|April 1, 2025
Detection of Outlying Correlation Coefficients in Multicenter Clinical TrialsLieven Desmet, David Venet, Laura Trotta, et al.
Pharmaceutical Statistics|March 27, 2025
Multiple Comparisons Procedures for Analyses of Joint Primary Endpoints and Secondary EndpointsXiaolong Luo, Lerong Li, Oleksandr Savenkov, et al.
Pharmaceutical Statistics|March 29, 2025
The Choice Between Pearson's χ<sup>2</sup> Test and Fisher's Exact Test for 2 × 2 TablesMarkus Neuhäuser, Graeme D Ruxton
Pharmaceutical Statistics|January 31, 2026
A Tobit Partly Linear Mixed and Mixture Cure Model for the Joint Analysis of Interval-Bounded Longitudinal Measurements and Survival Times With Cure ProportionZhanfeng Wang, Zerui Shen, Ruixing Ming, et al.
Pharmaceutical Statistics|January 19, 2026
Multiple Comparisons With Overdispersed Multinomial Data: Methods, Properties and ApplicationSören Budig, Charlotte Vogel, Frank Schaarschmidt
Pharmaceutical Statistics|February 21, 2013
A multistage analysis strategy for a clinical trial to assess successively more stringent criteria for a primary endpoint with a low event rateSiying Li, Michael A Hussey, Todd A Schwartz, et al.
Pharmaceutical Statistics|June 27, 2013
Subject-level matching for imbalance in cluster randomized trials with a small number of clustersAndrew C Leon, Hakan Demirtas, Chunshan Li, et al.
Pageof 124

Showing results (41-50 of 1,234) with videos related to

Sort By:
Pageof 124
Pharmaceutical Statistics|April 3, 2008
Exploring changes in treatment effects across design stages in adaptive trialsTim Friede, Robin Henderson
Pharmaceutical Statistics|April 3, 2008
Statisticians and evidence--mote and beamStephen Senn
Pharmaceutical Statistics|May 16, 2008
Pharmacokinetic parameters estimation using adaptive Bayesian P-splines modelsAstrid Jullion, Philippe Lambert, Benoit Beck, et al.
Pharmaceutical Statistics|April 1, 2025
Detection of Outlying Correlation Coefficients in Multicenter Clinical TrialsLieven Desmet, David Venet, Laura Trotta, et al.
Pharmaceutical Statistics|March 27, 2025
Multiple Comparisons Procedures for Analyses of Joint Primary Endpoints and Secondary EndpointsXiaolong Luo, Lerong Li, Oleksandr Savenkov, et al.
Pharmaceutical Statistics|March 29, 2025
The Choice Between Pearson's χ<sup>2</sup> Test and Fisher's Exact Test for 2 × 2 TablesMarkus Neuhäuser, Graeme D Ruxton
Pharmaceutical Statistics|January 31, 2026
A Tobit Partly Linear Mixed and Mixture Cure Model for the Joint Analysis of Interval-Bounded Longitudinal Measurements and Survival Times With Cure ProportionZhanfeng Wang, Zerui Shen, Ruixing Ming, et al.
Pharmaceutical Statistics|January 19, 2026
Multiple Comparisons With Overdispersed Multinomial Data: Methods, Properties and ApplicationSören Budig, Charlotte Vogel, Frank Schaarschmidt
Pharmaceutical Statistics|February 21, 2013
A multistage analysis strategy for a clinical trial to assess successively more stringent criteria for a primary endpoint with a low event rateSiying Li, Michael A Hussey, Todd A Schwartz, et al.
Pharmaceutical Statistics|June 27, 2013
Subject-level matching for imbalance in cluster randomized trials with a small number of clustersAndrew C Leon, Hakan Demirtas, Chunshan Li, et al.
Pageof 124